Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder (TreatChildTrauma) (TCT)

October 25, 2017 updated by: Lutz Goldbeck, University of Ulm

Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder

This multi-site randomized controlled trial compares the effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) as developed by Cohen, Mannarino & Deblinger (2006) with a wait-list condition in a population of children aged 7-16 years who were exposed to traumatic events beyond the age of three years, at least three months ago, and developed Posttraumatic Stress Disorder (PTSD). Primary aims are to provide evidence that TF-CBT exceeds spontaneous remission of posttraumatic stress symptoms and to assess maintenance of treatment gains at 6 and 12 months post-treatment. Secondary aims are to evaluate the effectiveness of TF-CBT in reducing other psychopathology and cognitive distortions of patients and caregivers and to explore moderators and mediators of treatment response. The trial will contribute to implement an evidence-based treatment for traumatized children across a variety of healthcare settings in Germany. The novel aspect is to evaluate the effectiveness of TF-CBT with a broad range of traumatized "real-world" patients in the context of the German mental healthcare system.

Study Overview

Detailed Description

Complete study protocol (in German) available from the PI lutz.goldbeck@uniklinik-ulm.de

Study Type

Interventional

Enrollment (Actual)

159

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 13407
        • Vivantes Klinik für Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik
      • Datteln, Germany, 45711
        • Vestische Kinder- und Jugendklinik Datteln
      • Lüneburg, Germany, 21339
        • Psychiatrische Klinik Lüneburg
      • Mannheim, Germany, 68072
        • Klinik für Psychiatrie und Psychotherapie
      • München, Germany, 80802
        • Traumaambulanz LMU
      • Ravensburg, Germany, 88214
        • ZfP Südwürttemberg Weissenau
      • Saarbrücken, Germany, 66119
        • Klinik für Kinder- und Jugendpsychiatrie und -psychotherapie
      • Ulm, Germany, 89075
        • Universitatsklinikum Ulm

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 7-16 years
  • Exposure to a traumatic event (index trauma) after the age of 3 years, at least 3 months before assessment
  • ≥35 points on the Clinician -Administered PTSD Scale for Children and Adolescents (CAPS-CA) total symptom severity score and at least one symptom per PTSD cluster related to the index trauma according to DSM IV diagnostic criteria
  • PTSD should be the main mental health problem, patients with co-morbid mental disorders are included
  • No major brain injury of the child due to the traumatic event (Glasgow Coma Scale <9 points at primary medical examination)
  • Co-operation of at least one non-offending primary caregiver (improves treatment outcome)
  • Living within reasonable distance (max 1 hour of travel) to the treatment center to allow treatment on a weekly basis (feasibility)

Exclusion Criteria:

  • Psychosis
  • Acute suicidality
  • Psychopharmacological medication started or changed up to 6 weeks before first assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TF-CBT

12 Sessions Trauma-focused Cognitive Behavioral Therapy including the child/adolescents and a non-abusive caregiver according to the treatment manual:

Cohen JA, Mannarino AP, and Deblinger E (2006) Treating Trauma and Traumatic Grief in Children and Adolenscents. Guilford, N.Y.

TF-CBT (see also HThttp://tfcbt.musc.eduTH) is a manualised intervention for traumatized children and adolescents 7 to 16 years old and their parent/caregiver. The primary components are summarized by the acronym PRACTICE: Parenting skills, Psychoeducation, Relaxation, Affect modulation, Cognitive processing, Trauma narrative, In vivo mastery of trauma reminders, Conjoint child-parent session, and Enhancing safety and future development. We will use the manual as provided by Cohen et al. and available in German. The treatment program will comprise 12 sessions with children and parents (partly separated, partly conjoined sessions) of 90 minutes each. The 12 sessions will be distributed over a duration of 16 weeks.
No Intervention: Wait-list
Patients in the control condition will be assigned to a wait-list (duration 4 months). During waiting time, clinical services will be provided as needed (excluding TF-CBT).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Clinician-Administered PTSD Scale for Children and Adolescents (CAPS-CA)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Symptom severity score
Change from Baseline at 16 weeks (=end of treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Schedule for Affective Disorders and Schizophrenia for School Aged Children (K-SADS-PL)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
change in co-morbid psychiatric disorders
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in Children's Global Assessment Scale (CGAS)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Global impairment
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in UCLA PTSD Reaction Index (self-report and caregiver report)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Post-traumatic stress symptoms
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in Self-report for childhood anxiety related disorders (SCARED; Self-report and caregiver report)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Anxiety
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in Children's Depression Inventory (CDI)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Depression
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in Child Behavior Checklist (CBCL 4/18)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
General Psychopathology
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen (ILK; Self-report and caregiver report)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Quality of Life
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in Child Post Traumatic Cognitions Inventory (CPTCI)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Trauma-related Cognitions (Child)
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in The Posttraumatic Cognitions Inventory (PTCI)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Trauma-related cognitions (Parent)
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in Posttraumatic Diagnostic Scale (PDS)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Parental symptoms: PTSD
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in Beck Depression Inventory (BDI-II)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Parental Symptoms: Depression
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in State-Trait-Anxiety-Inventory (STAI)
Time Frame: Change from Baseline at 8 weeks (=mid-treatment)
Parental symptoms: Anxiety
Change from Baseline at 8 weeks (=mid-treatment)
Change from Baseline in Children's Global Assessment Scale (CGAS)
Time Frame: Change from Baseline at 6 months post-treatment
Global impairment
Change from Baseline at 6 months post-treatment
Change from Baseline in Children's Global Assessment Scale (CGAS)
Time Frame: Change from Baseline at 12 months post-treatment
Global impairment
Change from Baseline at 12 months post-treatment
Change from Baseline in UCLA PTSD Reaction Index (self-report and caregiver report)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in UCLA PTSD Reaction Index (self-report and caregiver report)
Time Frame: Change rom Baseline at 6 months post-treatment
Change rom Baseline at 6 months post-treatment
Change from Baseline in UCLA PTSD Reaction Index (self-report and caregiver report)
Time Frame: Change from baseline at 12 months post-treatment
Change from baseline at 12 months post-treatment
Change from Baseline in Self-report for childhood anxiety related disorders (SCARED; Self-report and caregiver report)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in Self-report for childhood anxiety related disorders (SCARED; Self-report and caregiver report)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in Self-report for childhood anxiety related disorders (SCARED; Self-report and caregiver report)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from Baseline in Children's Depression Inventory (CDI)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in Children's Depression Inventory (CDI)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in Children's Depression Inventory (CDI)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from Baseline in Child Behavior Checklist (CBCL 4/18)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in Child Behavior Checklist (CBCL 4/18)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in Child Behavior Checklist (CBCL 4/18)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from Baseline in Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen (ILK; Self-report and caregiver report)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen (ILK; Self-report and caregiver report)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen (ILK; Self-report and caregiver report)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from Baseline in Child Post Traumatic Cognitions Inventory (CPTCI)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in Child Post Traumatic Cognitions Inventory (CPTCI)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in Child Post Traumatic Cognitions Inventory (CPTCI)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from Baseline in The Posttraumatic Cognitions Inventory (PTCI)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in The Posttraumatic Cognitions Inventory (PTCI)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in The Posttraumatic Cognitions Inventory (PTCI)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from Baseline in Posttraumatic Diagnostic Scale (PDS)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in Posttraumatic Diagnostic Scale (PDS)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in Posttraumatic Diagnostic Scale (PDS)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from Baseline in Beck Depression Inventory (BDI-II)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in Beck Depression Inventory (BDI-II)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in Beck Depression Inventory (BDI-II)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from Baseline in State-Trait-Anxiety-Inventory (STAI)
Time Frame: Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline at 16 weeks (=end of treatment)
Change from Baseline in State-Trait-Anxiety-Inventory (STAI)
Time Frame: Change from Baseline at 6 months post-treatment
Change from Baseline at 6 months post-treatment
Change from Baseline in State-Trait-Anxiety-Inventory (STAI)
Time Frame: Change from Baseline at 12 months post-treatment
Change from Baseline at 12 months post-treatment
Change from baselinein Clinician-Administered PTSD Scale for Children and Adolescents (CAPS-CA)
Time Frame: Change from Baseline at 6 monts post-treatment
Symptom severity score
Change from Baseline at 6 monts post-treatment
Change from Baseline in Clinician-Administered PTSD Scale for Children and Adolescents (CAPS-CA)
Time Frame: Change from baseline at 12 months post-treatment
Symptom severity score
Change from baseline at 12 months post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lutz Goldbeck, Ph.D., University Ulm

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

December 13, 2011

First Submitted That Met QC Criteria

January 19, 2012

First Posted (Estimate)

January 25, 2012

Study Record Updates

Last Update Posted (Actual)

October 27, 2017

Last Update Submitted That Met QC Criteria

October 25, 2017

Last Verified

October 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Traumatic Stress Disorder

Clinical Trials on Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)

3
Subscribe